$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Antiviral oligonucleotides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-043/04
출원번호 US-0073014 (2008-02-28)
등록번호 US8008269 (2011-08-15)
발명자 / 주소
  • Vaillant, Andrew
  • Juteau, Jean-Marc
출원인 / 주소
  • Replicor Inc.
대리인 / 주소
    Norton Rose Or LLP
인용정보 피인용 횟수 : 5  인용 특허 : 66

초록

Random sequence oligonucleotides that have antiviral activity are described, along with their use as antiviral agents. In many cases, the oligonucleotides are greater than 40 nucleotides in length. Also described are methods for the prophylaxis or treatment of a viral infection in a human or animal,

대표청구항

The invention claimed is: 1. An antiviral oligonucleotide formulation comprising at least one fully phosphorothioated antiviral oligonucleotide, wherein said oligonucleotide is between 20 and 120 nucleotides in length, wherein the antiviral activity of said oligonucleotide occurs by a non-sequence d

이 특허에 인용된 특허 (66)

  1. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), 4′-desmethyl nucleoside analog compounds.
  2. Rando Robert F. ; Fennewald Susan ; Zendegui Joseph G. ; Oiwana Joshua O. ; Hogan Michael E., Anti-viral guanosine-rich oligonucleotides.
  3. McKay Robert ; Dean Nicholas ; Monia Brett P. ; Nero Pamela S. ; Gaarde William A., Antisense oligonucleotide compositions and methods for the modulation of JNK proteins.
  4. Peyman Anuschirwan (Kelkheim DEX) Uhlmann Eugen (Glashutten DEX) Mag Matthias (Oberursel DEX) Kretzschmar Gerhard (Eschborn DEX) Helsberg Matthias (Kelkheim DEX) Winkler Irvin (Liederbach DEX), Antisense oligonucleotides against HSV 1, and their preparation.
  5. Draper Kenneth G. (San Marcos CA) Ecker David J. (Carlsbad CA) Mirabelli Christopher K. (Encinitas CA) Crooke Stanley T. (Carlsbad CA), Antisense oligonucleotides for inhibiting herpesviruses.
  6. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  7. Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling.
  8. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  9. Robinson Joseph R. (Madison WI), Bioadhesive compositions and methods of treatment therewith.
  10. Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same.
  11. Draper Kenneth G. ; Kisner Daniel L. ; Anderson Kevin P. ; Chapman Sharon, Composition and method for treatment of CMV infections.
  12. Monia Brett P. ; Freier Susan M. ; Ecker David J., Compositions and methods for modulating .beta.-amyloid.
  13. Monia Brett P. ; Freier Susan M. ; Ecker David J., Compositions and methods for modulating .beta.-amyloid.
  14. Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Delivery of exogenous DNA sequences in a mammal.
  15. Junichi Yano,JPX ; Ohgi Tadaaki,JPX, Drug composition containing nucleic acid copolymer.
  16. Tagawa Toshiaki (Yokohama JPX) Hosokawa Saiko (Kawasaki JPX) Nagaike Kazuhiro (Sagamihara JPX), Drug-containing protein-bonded liposome.
  17. Froehler Brian C. (Belmont CA), Exonuclease-resistant oligonucleotides.
  18. Peyman Anuschirwan,DEX ; Uhlmann Eugen,DEX, G cap-stabilized oligonucleotides.
  19. Graham, Michael Wayne, Genetic constructs for delaying or repressing the expression of a target gene.
  20. Fire, Andrew; Kostas, Stephen; Montgomery, Mary; Timmons, Lisa; Xu, SiQun; Tabara, Hiroaki; Driver, Samuel E.; Mello, Craig C., Genetic inhibition by double-stranded RNA.
  21. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  22. Metelev Valeri,RUX ; Agrawal Sudhir, Hybrid oligonucleotide phosphorothioates.
  23. Valeri Metelev RU; Sudhir Agrawal, Hybrid oligonucleotide phosphorothioates.
  24. Goodchild John (Worcester MA) Zamecnik Paul C. (Shrewsbury MA), Inhibition of HTLV-III by exogenous oligonucleotides.
  25. Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DEX), Inhibition of reverse transcriptase by phosphorodithioates.
  26. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  27. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  28. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  29. Arnold ; Jr. Lyle J. ; Reynolds Mark A. ; Giachetti Cristina, Method for inhibiting RNA translation using chimeric oligonucleoside compounds.
  30. Agrawal Sudhir (Shrewsbury MA) Diasio Robert B. (Birmingham AL) Zhang Ruiwen (Birmingham AL), Method of down-regulating gene expression.
  31. Agrawal, Sudhir; Diasio, Robert B.; Zhang, Ruiwen, Method of down-regulating gene expression.
  32. Rahman Aquilur (Gaithersburg MD) Thierry Alain (Washington DC) Dritschilo Anatoly (Bethesda MD), Method of making liposomal oligodeoxynucleotide compositions.
  33. Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
  34. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Huang Shi K. (Castro Valley CA), Method of treatment of inflamed tissues.
  35. Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA) Radhakrishnan Ramachandran (Fremont CA), Microreservoir liposome composition and method.
  36. Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  37. Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  38. Behr Jean-Paul,FRX ; Demeneix Barbara,FRX ; Lezoualch Franck,FRX ; Mergny Mojgan,FRX ; Scherman Daniel,FRX ; Boussif Otmane,FRX, Nucleic acid containing composition, preparation and uses of same.
  39. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel CHX), Nucleoside phosphinate compounds and compositions.
  40. Caruthers Marvin H. (Boulder CO) Brill Wolfgang K. D. (Schopfheim DEX) Yau Eric (Mercer Island WA) Ma Michael (New York NY) Nielsen John (Horsholm DKX), Nucleoside thiophosphoramidites.
  41. Caruthers Marvin H. (Boulder CO) Ma Yun-Xi (Mississauga WA CAX) Yau Eric K. (Kirkland WA) Nielsen John (Horsholm DKX) Brill Wolfgang (Freiburg DEX), Nucleoside thiophosphoramidites.
  42. Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  43. Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  44. Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  45. Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  46. Bennett C. Frank (Carlsbad CA) Mirabelli Christopher K. (Encinitas CA), Oligonucleotide modulation of cell adhesion.
  47. Bennett C. Frank (Carlsbad CA) Mirabelli Christopher K. (Encinitas CA), Oligonucleotide modulation of cell adhesion.
  48. Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  49. Anderson Kevin P. (Carlsbad CA) Draper Kenneth G. (Richmond OH), Oligonucleotides for modulating the effects of cytomegalovirus infections.
  50. Hanecak Ronnie C. ; Anderson Kevin P. ; Bennett C. Frank ; Chiang Ming-Yi ; Brown-Driver Vickie L. ; Ecker David J. ; Vickers Timothy A. ; Wyatt Jacqueline R. ; Imbach Jean Louis,FRX, Oligonucleotides having a conserved G4 core sequence.
  51. Rein Alan ; Casas-Finet Jose ; Fisher Robert ; Fivash Matthew ; Henderson Louis E., Oligonucleotides which specifically bind retroviral nucleocapsid proteins.
  52. Tagawa Toshiaki (Yokohama JPX) Awane Kaoru (Yokohama JPX) Nagaike Kazuhiro (Sagamihara JPX), Phospholipid derivatized with PEG bifunctional linker and liposome containing it.
  53. Imbach Jean-Louis,FRX ; Rayner Bernard,FRX, Phosphorothioate triester oligonucleotides and method of preparation.
  54. Caruthers Marvin H. (Boulder CO) Brill Wolfgang K.-D. (Schopfheim DEX) Yau Eric (Mercer Island WA) Ma Michael (New York NY) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate compounds.
  55. Caruthers Marvin H. ; Brill Wolfgang K.-D,DEX ; Yau Eric ; Ma Michael ; Nielsen John,DKX, Polynucleotide phosphorodithioate compounds.
  56. Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  57. Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Ramsay Shaw Barbara (Durham NC), Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  58. Torrence Paul F. ; Silverman Robert Hugh ; Cirino Nick Mario ; Li Guiying ; Xiao Wei, RNase L activators and antisense oligonucleotides effective to treat RSV infections.
  59. Miyazaki Tsuyoshi (Tsukuba JPX) Maruyama Kazuo (Sagamihara JPX) Iwatsuru Motoharu (Hachioji JPX) Sanchika Kouzoh (Kawasaki JPX) Nishida Mitsuhiro (Amagasaki JPX) Yasukohchi Tohru (Kawasaki JPX) Kitan, Reactive vesicle and functional substance-fixed vesicle.
  60. Marotta Charles A. (Cambridge MA) Majocha Ronald E. (Needham MA) Agrawal Sudhir (Shrewsbury MA), Reversal of b 상세보기
  • Martin Francis J. (San Francisco CA) Woodle Martin C. (Menlo Park CA) Redemann Carl (Walnut Creek CA) Yau-Young Annie (Palo Alto CA), Solid tumor treatment method and composition.
  • Webb Murray S. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX) Mayer Lawrence D. (North Vancouver CAX), Sphingosomes for enhanced drug delivery.
  • Sears Barry D. (Marblehead MA), Synthetic phospholipid compounds.
  • Sears Barry D. (Marblehead MA), Synthetic phospholipid compounds.
  • Hseih Dean (Brandamore PA), Transdermal and trans-membrane delivery of drugs.
  • Long James M. (Toledo OH) Nijakowski Timothy M. (Swanton OH), Vacuum assisted accumulator and process of collecting microfiber.
  • 이 특허를 인용한 특허 (5)

    1. Bazinet, Michel; Vaillant, Andrew, Methods for the treatment of hepatitis B and hepatitis D infections.
    2. Bazinet, Michel; Vaillant, Andrew, Methods for the treatment of hepatitis B and hepatitis D infections.
    3. Vaillant, Andrew, Methods for the treatment of hepatitis B and hepatitis D virus infections.
    4. Niazi, Kayvan; Rabizadeh, Shahrooz; Le Ny, Anne-Laure; Buzko, Oleksandr; Golovato, Justin; Soon-Shiong, Patrick, Small molecule inhibitors of influenza A RNA-dependent RNA polymerase.
    5. Niazi, Kayvan; Rabizadeh, Shahrooz; Le Ny, Anne-Laure; Buzko, Oleksandr; Golovato, Justin; Soon-Shiong, Patrick, Small molecule inhibitors of influenza A RNA-dependent RNA polymerase.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로